Advanced Therapies Panel: Apomorphine (2021)

In this webinar, Dr. Anish Kanungo, a movement disorder specialist, along with carepartner David Giesbrecht, delved into the intricacies of utilizing apomorphine as a potential treatment for Parkinson's disease. The discussion revolved around the medication's mechanism of action, administration methods, and considerations for Parkinson's patients and their caregivers.

Apomorphine's capacity to bind to dopamine receptors, offering rapid relief with minimal gastrointestinal side effects, was a key focal point. While acknowledging its short duration of effect, the talk underscored the necessity of understanding individual variations in response and the need for further research on its overall efficacy and potential side effects.

Detailed insights into the practical aspects of utilizing apomorphine were provided, emphasizing the significance of caregivers in ensuring timely administration and addressing medication costs and coverage under BC Pharmacare. The discussion also highlighted the promising future prospects of apomorphine subcutaneous pumps as a viable therapeutic option.

Real-life experiences shared by a patient underscored the positive impact of apomorphine while shedding light on the challenges associated with its management and infection prevention.

View the video slides accompanying this presentation by clicking here.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**